Evidence map›Paper›PMID 40486757›Full record

ArticleOne health (Amsterdam, Netherlands)2025

Global phylogenetic analysis and emergence of carbapenem-resistant

Xinru Wang, Ying Zhang, Jie Sheng, Longjie Zhou, Jiayao Yao, Yueyue Hu, Xiufang Xu, Yunsong Yu, Xi Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinru WangSchool of Public Health, Hangzhou Medical College, Hangzhou 310063, Zhejiang Province, China.
Ying ZhangSchool of Public Health, Hangzhou Medical College, Hangzhou 310063, Zhejiang Province, China.
Jie ShengCentre of Laboratory Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Longjie ZhouSchool of Public Health, Hangzhou Medical College, Hangzhou 310063, Zhejiang Province, China.
Jiayao YaoSchool of Public Health, Hangzhou Medical College, Hangzhou 310063, Zhejiang Province, China.
Yueyue HuCentre of Laboratory Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Xiufang XuSchool of Public Health, Hangzhou Medical College, Hangzhou 310063, Zhejiang Province, China.
Yunsong YuCentre of Laboratory Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Xi LiCentre of Laboratory Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: A carbapenem-resistant clinical isolate of Results: Conclusion: To our knowledge, this is the first report of an IncX3 type plasmid carrying

Indexed as

Escherichia fergusoniiIncX3Multi-drug resistantNDM-5

Identifiers

PMID40486757
PMCPMC12143760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.